findmyKOL
Clinical trialNCT06822166CompletedPhase 1Interventional

Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride

SponsorAhon Pharmaceutical Co., Ltd.Enrollment68Interaction Drug Food
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Wei Zhao, Doctor

    The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital of Shandong Province)

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • the First Affiliated Hospital of Shandong First Medical University (qianfoshan Hospital of Shandong Province)

    Jinan, Shandong, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Dec 2023
Primary completion
23 Jan 2024
Completion
23 Jan 2024
Last update posted
14 Feb 2025
Registered enrollment
68
Registry id
NCT06822166

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.